Johannes Richard Bogner

机构：LMU Klinikum, Ludwig-Maximilians-Universität München · ORCID：0000-0001-8628-1533

发表论文 419 篇 · 总被引 17916 次 · h-index 44

代表论文

• Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials (2023 · The Lancet HIV · 被引 34)
• Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial (2024 · The Lancet HIV · 被引 33)
• Characterization of cognitive symptoms in post COVID-19 patients (2024 · European Archives of Psychiatry and Clinical Neuroscience · 被引 15)
• Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial (2025 · Clinical Infectious Diseases · 被引 14)
• Mpox-Specific Immune Responses Elicited by Vaccination or Infection in People With HIV (2024 · The Journal of Infectious Diseases · 被引 12)
• Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+ T cells (2025 · JCI Insight · 被引 9)